Gene expression profiling in TPC1 cell line treated with the RTK inhibitor RPI-1
Ontology highlight
ABSTRACT: We treated the papillary thyroid carcinoma-derived cell line TPC1 with the RTK inhibitor RPI-1 to obtain a thyroid carcinoma cell model. The RET tyrosine kinase is a target of the inhibitor. Gene expression changes were evaluated comparing cells treated with the inhibitor for 24 hours versus cells treated with DMSO for 24 hours.
ORGANISM(S): Homo sapiens
PROVIDER: GSE49414 | GEO | 2014/06/30
SECONDARY ACCESSION(S): PRJNA213907
REPOSITORIES: GEO
ACCESS DATA